Levocarnitine propionate

DB15980InvestigationalSmall molecule

Levocarnitine propionate is a medication indicated in the treatment of peripheral arterial disease and to increase exercise tolerance in congestive heart disease. A medication used in the treatment of heart failure and diseases of the arteries.

Chemical structure of Levocarnitine propionate
Formula / weight
C10H19NO4 · 217.265 g/mol (avg)
Also known as
L-Carnitine propionate · Propionyl-L-carnitine

Resolves to

Compound
UNII0HU2UI27HFCAS20064-19-1ChEMBLCHEMBL3392074ChEBI53210
Structure
InChIKeyUFAHZIUFPNSHSL-MRVPVSSYSA-NSMILESCCC(=O)O[C@H](CC([O-])=O)C[N+](C)(C)C

What you can answer from here — as of July 17, 2026

6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Levocarnitine propionate, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In